SENIORS is also the first major trial to test beta blockers in patients with preserved ejection fractions and showed similar benefits of nebivolol in this population as seen in patients with ...

The beta-blocker nebivolol was shown to be an effective agent, significantly reducing cardiovascular death or hospitalization in these patients. [1] The effect was similar regardless of ejection ...

Background The risks associated with using an angiotensin-converting-enzyme (ACE) inhibitor and an angiotensin-receptor blocker together are unclear. This study was designed to determine the safety of ...

Beta blockers are drugs that block adrenaline in the body, allowing the heart to beat more slowly and lowering blood pressure. They allow blood vessels to relax, increasing blood flow.

The study ran from 2018 to 2023. "Beta blocker treatment led to a modest increase in depressive symptoms" for heart attack survivors who weren't in heart failure, the researchers reported.

NEW DELHI: Beta-blockers, drugs prescribed commonly to people suffering from irregular heartbeat and hypertension among other ailments, can lead to dangerously low potassium levels or hypokalaemia ...